Be a Smart Investor
Sunday, March 5, 2017
Who Will Win Ampyra Patent Fight - Acorda Or Kyle Bass?
The decision on inter partes review related to Acorda Therapeutics Inc.'s (ACOR) Ampyra is expected this month.
from RTT - Biotech http://ift.tt/2mKxyGq
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment